Supernus Pharmaceuticals Inc (SUPN)
Cost of Revenue
$33.67M
Quarterly · Period ending: · USD
SUPN Cost of Revenue
Latest reported$33.67Mperiod ending
Latest reported$33.67Mperiod ending
SUPN Quarterly Cost of Revenue (-$8.59M → $33.67M)
Quarterly cost of revenue
High-resolution chart · PNG
SUPN cost of revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 33,669,000 | |
| 23,391,000 | |
| 23,007,000 | |
| 18,965,000 | |
| 16,827,000 | |
| 15,763,000 | |
| 26,098,000 | |
| 17,583,000 | |
| 17,916,000 | |
| 16,309,000 | |
| 19,627,000 | |
| 19,601,000 | |
| 21,091,000 | |
| 23,460,000 | |
| 22,954,000 | |
| 25,878,000 | |
| 20,457,000 | |
| 17,932,000 | |
| 16,994,000 | |
| 18,085,000 | |
| 25,028,000 | |
| 14,954,000 | |
| 18,533,000 | |
| 21,388,000 | |
| 8,386,000 | |
| 4,152,000 | |
| 4,113,000 | |
| 4,819,000 | |
| 4,044,000 | |
| 3,684,000 | |
| 4,188,000 | |
| 4,207,000 | |
| 3,683,000 | |
| 3,278,000 | |
| 4,154,000 | |
| 4,251,000 | |
| 3,861,000 | |
| 2,949,000 | |
| 3,771,000 | |
| 3,428,000 | |
| 2,751,000 | |
| 2,035,000 | |
| 2,794,000 | |
| 2,248,000 | |
| 1,762,000 | |
| 1,618,000 | |
| 2,282,000 | |
| 1,321,000 | |
| 1,661,000 | |
| 494,000 | |
| 1,066,000 | |
| 33,000 | |
| 4,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| -13,404,000 | |
| -8,588,146 |